← Scroll for more →
Financial Statements — SPCB
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.83 | 3.15 | 15.03 | 5.21 | 1.14 | 4.04 | 2.91 | 3.54 | 9.42 |
| Short-term Investments | 2.37 | -- | -- | -- | -- | -- | -- | -- | -- |
| Accounts Receivable | 15.05 | 12.77 | 19.83 | 13.36 | 12.43 | 10.85 | 12.50 | 11.06 | 13.57 |
| Inventory | 2.21 | 2.52 | 2.63 | 2.50 | 3.06 | 3.41 | 3.64 | 3.56 | 3.57 |
| Total Current Assets | 37.35 | 26.26 | 45.18 | 28.46 | 24.65 | 26.29 | 27.14 | 26.11 | 34.18 |
| Property, Plant & Equipment | 3.02 | 3.26 | 4.06 | 2.70 | 2.40 | 1.64 | 1.74 | 1.80 | 1.63 |
| Goodwill | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 | 7.03 |
| Intangible Assets | 5.79 | 5.64 | -- | 5.58 | -- | 5.62 | -- | 6.49 | -- |
| Total Non-current Assets | 31.02 | 19.66 | 20.30 | 16.29 | 16.15 | 15.75 | 15.54 | 16.01 | 15.12 |
| Total Assets | 68.38 | 45.92 | 65.48 | 44.75 | 40.79 | 42.04 | 42.68 | 42.12 | 49.30 |
| Short-term Debt | 0.36 | 0.42 | -- | 0.79 | -- | 0.90 | -- | 0.21 | -- |
| Total Current Liabilities | 4.69 | 3.75 | 4.39 | 5.40 | 3.45 | 5.24 | 5.20 | 5.60 | 9.67 |
| Long-term Debt | 18.71 | 0.12 | 23.62 | 0.11 | 32.91 | 32.60 | 32.34 | 30.45 | 28.54 |
| Total Non-current Liabilities | 20.18 | 30.48 | 23.84 | 34.53 | 33.88 | 33.67 | 33.76 | 32.12 | 29.28 |
| Total Liabilities* | 24.87 | 34.23 | 28.23 | 39.94 | 37.33 | 38.91 | 38.96 | 37.73 | 38.94 |
| Retained Earnings | (102.54) | (106.29) | (100.97) | (106.95) | (105.52) | (102.93) | (100.63) | (95.47) | (87.60) |
| Total Stockholder Equity | 43.51 | 11.70 | 37.25 | 4.82 | 3.47 | 3.13 | 3.73 | 4.39 | 10.35 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Total Revenue | 14.19 | 14.12 | 6.26 | 6.13 |
| Cost of Revenue | 5.51 | 10.28 | 3.65 | 2.67 |
| Gross Profit | 8.68 | 3.85 | 2.62 | 3.46 |
| Research & Development | 1.81 | 1.66 | 1.79 | 1.25 |
| Selling, General & Admin | 3.06 | 2.37 | 2.49 | 1.81 |
| Total Operating Expenses | 6.36 | 5.57 | 5.74 | 3.80 |
| Operating Income | 2.32 | (1.72) | (3.13) | (0.34) |
| Pretax Income | 5.32 | (2.59) | (5.16) | (2.26) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Income | 5.32 | (2.59) | (5.16) | (2.27) |
| Basic EPS | 1.32 | (0.53) | (0.15) | (0.09) |
| Diluted EPS | 1.32 | (0.53) | (0.15) | (0.09) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Operating Cash Flow | (2.18) | (3.41) | (4.13) | (4.19) |
| Capital Expenditures | 1.42 | 1.04 | 0.28 | 0.49 |
| Free Cash Flow* | (3.60) | (4.45) | (4.41) | (4.68) |
| Investing Cash Flow | (2.36) | (1.75) | (0.82) | (0.80) |
| Financing Cash Flow | 16.42 | 2.17 | 4.27 | 11.92 |
← Scroll for more columns →
* Derived from reported values